National Healthcare Properties Inc

Análisis de la acción National Healthcare Properties Inc (NHP)

$15.800

+1.125 (+7.12%)Al cierre

Loading chart…
Máximo
15.830
Apertura
14.550
Precio medio ponderado por volumen
15.31
Volumen
2.35M
Capitalización
—
Mínimo
14.310
Importe
35.97M
EV/EBITDA, TTM
13.80

National Healthcare Properties, Inc. is a real estate investment trust, which is focused on acquiring, owning and managing a diversified portfolio of healthcare real estate assets focused on senior housing operating properties (SHOP) and outpatient medical facilities (OMF) in the United States. It has two operating and reportable segments: SHOP and OMF. In the SHOP segment, the Company invests in senior housing properties. In the OMF segment, it owns, manages and leases single and multi-tenant OMFs. It owns over 167 properties and a land parcel located in 29 states, consisting of 37 senior housing communities, with 3,615 units, in its SHOP segment and 130 outpatient medical facilities, with approximately 3.7 million square feet in OMF segment. Its properties include Surgery Center of Temple - Temple, TX, Greenville Health System - Greenville, SC; Stockbridge Family Medical - Stockbridge, GA; Berwyn Medical Center - Berwyn, IL; Countryside Medical Arts - Safety Harbor, FL, and others.

nhpreit.com

Análisis de IA of National Healthcare Properties Inc (NHP)

Mantener

Currently, National Healthcare Properties, Inc. (NHP) is not a strong buy. The stock is trading at $15.11, with a recent RSI of 38.944, indicating it is nearing oversold territory. However, the company has reported a significant net loss of $8.14 million in Q2 2026, which raises concerns about its profitability. Despite a positive year-to-date change of +25.92%, the recent 5-day change of -2.80% suggests short-term weakness. The analyst price targets suggest an upside potential of approximately 12% to 39% from the current price, but the ongoing net losses and a high debt-to-equity ratio of 80.23% present risks that investors should consider before making a purchase.

Métricas de valoración

El PER previsto actual de National Healthcare Properties Inc (NHP) es 0.00, frente a su media de 5 años de .

PER previsto

Media 5A P/E
P/E actual
0.00

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
15.44
EV/EBITDA actual
13.80
Sobrevalorada
17.45
Infravalorada
13.44

Precio/ventas previsto

Valor razonable
Media 5A P/S
2.64
P/S actual
2.33
Sobrevalorada
2.98
Infravalorada
2.29

Ballenas con NHP en cartera

L

LaSalle Investment Management Securities, LLC

+ Con en carteraNHP

-7.16%

Rentabilidad a 3 meses

Preguntas frecuentes sobre NHP, respondidas por Alphio AI

National Healthcare Properties, Inc. is a real estate investment trust, which is focused on acquiring, owning and managing a diversified portfolio of healthcare real estate assets focused on senior housing operating properties (SHOP) and outpatient medical facilities (OMF) in the United States. It has two operating and reportable segments: SHOP and OMF. In the SHOP segment, the Company invests in senior housing properties. In the OMF segment, it owns, manages and leases single and multi-tenant OMFs. It owns over 167 properties and a land parcel located in 29 states, consisting of 37 senior housing communities, with 3,615 units, in its SHOP segment and 130 outpatient medical facilities, with approximately 3.7 million square feet in OMF segment. Its properties include Surgery Center of Temple - Temple, TX, Greenville Health System - Greenville, SC; Stockbridge Family Medical - Stockbridge, GA; Berwyn Medical Center - Berwyn, IL; Countryside Medical Arts - Safety Harbor, FL, and others. It operates in the Real Estate sector.

Currently, National Healthcare Properties, Inc. (NHP) is not a strong buy. The stock is trading at $15.11, with a recent RSI of 38.944, indicating it is nearing oversold territory. However, the company has reported a significant net loss of $8.14 million in Q2 2026, which raises concerns about its profitability. Despite a positive year-to-date change of +25.92%, the recent 5-day change of -2.80% suggests short-term weakness. The analyst price targets suggest an upside potential of approximately 12% to 39% from the current price, but the ongoing net losses and a high debt-to-equity ratio of 80.23% present risks that investors should consider before making a purchase.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar